Jane Street’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Jane Street's STOK Position: Q3 2026 in Review
Jane Street reduced its Stoke Therapeutics (STOK) stake by 82% in Q3 2026, selling an estimated $8.19M and leaving 60,556 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #5611.
Jane Street first reported a position in STOK in Q2 2020 and has held it in 18 quarters since. The position peaked at $10.9M in Q2 2026. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Jane Street held 60,556 shares of Stoke Therapeutics worth $1.57M as of Q3 2026.
- Jane Street sold 271,145 Stoke Therapeutics shares in Q3 2026, an estimated $8.19M.
- Stoke Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #5611 holding.
- Jane Street first reported a position in Stoke Therapeutics in Q2 2020 and has held it in 18 quarters since.
- Jane Street's Stoke Therapeutics position peaked at $10.9M in Q2 2026.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.